vTv Therapeutics Inc.
VTVT
$20.80
$0.723.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -319.54% | 1,385.71% | |||
| Gross Profit | 320.60% | -1,385.71% | |||
| SG&A Expenses | -18.49% | -11.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.55% | -9.07% | |||
| Operating Income | 24.81% | 9.07% | |||
| Income Before Tax | 24.02% | 8.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.02% | 8.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -24.03% | -14.00% | |||
| Net Income | 24.02% | 7.66% | |||
| EBIT | 24.81% | 9.07% | |||
| EBITDA | 24.89% | 9.09% | |||
| EPS Basic | 37.03% | -8.37% | |||
| Normalized Basic EPS | 37.02% | -9.59% | |||
| EPS Diluted | 37.03% | -8.37% | |||
| Normalized Diluted EPS | 37.02% | -9.59% | |||
| Average Basic Shares Outstanding | 20.65% | -14.79% | |||
| Average Diluted Shares Outstanding | 20.65% | -14.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||